UBS Group’s Health Catalyst HCAT Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $676K | Sell |
179,427
-1,420
| -0.8% | -$5.35K | ﹤0.01% | 4627 |
|
2025
Q1 | $819K | Sell |
180,847
-47,408
| -21% | -$215K | ﹤0.01% | 4341 |
|
2024
Q4 | $1.61M | Buy |
228,255
+124,922
| +121% | +$883K | ﹤0.01% | 3888 |
|
2024
Q3 | $841K | Sell |
103,333
-6,366
| -6% | -$51.8K | ﹤0.01% | 3722 |
|
2024
Q2 | $701K | Sell |
109,699
-42,289
| -28% | -$270K | ﹤0.01% | 3684 |
|
2024
Q1 | $1.14M | Buy |
151,988
+50,833
| +50% | +$383K | ﹤0.01% | 3452 |
|
2023
Q4 | $937K | Buy |
101,155
+36,244
| +56% | +$336K | ﹤0.01% | 3490 |
|
2023
Q3 | $657K | Buy |
64,911
+22,611
| +53% | +$229K | ﹤0.01% | 3415 |
|
2023
Q2 | $529K | Buy |
42,300
+17,036
| +67% | +$213K | ﹤0.01% | 3788 |
|
2023
Q1 | $295K | Buy |
25,264
+542
| +2% | +$6.33K | ﹤0.01% | 4074 |
|
2022
Q4 | $263K | Buy |
24,722
+18,597
| +304% | +$198K | ﹤0.01% | 4173 |
|
2022
Q3 | $59K | Buy |
6,125
+2,801
| +84% | +$27K | ﹤0.01% | 5114 |
|
2022
Q2 | $48K | Sell |
3,324
-20,021
| -86% | -$289K | ﹤0.01% | 4939 |
|
2022
Q1 | $610K | Sell |
23,345
-22,437
| -49% | -$586K | ﹤0.01% | 3633 |
|
2021
Q4 | $1.81M | Buy |
45,782
+30,388
| +197% | +$1.2M | ﹤0.01% | 2948 |
|
2021
Q3 | $770K | Buy |
15,394
+5,683
| +59% | +$284K | ﹤0.01% | 3436 |
|
2021
Q2 | $539K | Sell |
9,711
-21,021
| -68% | -$1.17M | ﹤0.01% | 3693 |
|
2021
Q1 | $1.44M | Sell |
30,732
-2,402
| -7% | -$112K | ﹤0.01% | 3036 |
|
2020
Q4 | $1.44M | Buy |
33,134
+26,485
| +398% | +$1.15M | ﹤0.01% | 2884 |
|
2020
Q3 | $244K | Sell |
6,649
-804
| -11% | -$29.5K | ﹤0.01% | 3876 |
|
2020
Q2 | $218K | Sell |
7,453
-10,722
| -59% | -$314K | ﹤0.01% | 3958 |
|
2020
Q1 | $476K | Sell |
18,175
-1,011
| -5% | -$26.5K | ﹤0.01% | 3249 |
|
2019
Q4 | $666K | Sell |
19,186
-10,949
| -36% | -$380K | ﹤0.01% | 3663 |
|
2019
Q3 | $954K | Buy |
+30,135
| New | +$954K | ﹤0.01% | 3226 |
|